•  
  •  
 

Aims & Scope

The Journal of Food and Drug Analysis (JFDA) is the official peer-reviewed open access publication of the Food and Drug Administration, Taiwan (TFDA). Since its inception in 1993, the journal has served as a vital international platform for researchers to share significant findings and discuss current issues in the biomedical and food sciences.

Under the new editorial leadership, JFDA aims to move beyond purely analytical methodologies. Our vision is to publish high-quality, impactful research that advances the fundamental understanding of safety, efficacy, and quality across the multidisciplinary fields of food, drugs, medical devices, and cosmetics. We prioritize manuscripts that demonstrate conceptual novelty and provide solutions to complex challenges in public health and regulatory science.

Scope of the Journal

The JFDA welcomes original research, comprehensive reviews, and perspectives that address critical developments in the following areas:

  1. Pharmaceutical Sciences and Drug Development
    1. Discovery and Innovation: Research focusing on drug discovery, medicinal chemistry, and the evaluation of new chemical or biological entities (e.g., ADCs, peptides, and nucleic acid modalities).
    2. Delivery Science: Advances in drug delivery systems, controlled-release technologies, and formulation science that improve therapeutic outcomes.
    3. Pharmacology and Toxicology: Studies on drug absorption, metabolism, pharmacokinetics (PK), and pharmacodynamics (PD), including translational pharmacology and personalized medicine.
    4. Clinical Evaluation: Research involving clinical trials, drug evaluation in the clinic, and treatments for specific populations such as pediatrics or the elderly.
  2. Medical Devices and Health Technologies
    1. Design and Performance: Research on the development, characterization, and clinical performance of innovative medical devices and biomaterials.
    2. Digital Health: Integration of AI, machine learning, and sensor technologies in diagnostics, wearable devices, and point-of-care testing.
    3. Safety and Biocompatibility: Assessments of device-host interactions, material safety, and regulatory evaluation of emerging medical technologies.
  3. Food Science, Nutrition, and Safety
    1. Functional Insights: Exploration of the biological activities of food components and their impact on human health and disease prevention.
    2. Risk Assessment: Innovative research on food safety, toxicology, contaminants, and the development of risk-based monitoring strategies.
    3. Food Integrity: Advances in food chemistry, molecular biology (such as raw material variety identification), processing and traceability that ensure the quality and authenticity of the global food supply.
  4. Natural Products and Traditional Chinese Medicine (TCM)
    1. Biological Efficacy: Holistic studies on the pharmacological effects and mechanisms of action of natural products and TCM.
    2. Special Requirement for Quality Assurance: To ensure scientific reproducibility and the validity of biological findings, manuscripts investigating the efficacy of plant extracts or natural compounds must include comprehensive chemical characterization and quantitative analysis of the major active constituents (e.g., via HPLC, GC-MS, or LC-MS/MS).
  5. Digital and Intelligent Technologies in Food and Drug Administration
    1. AI-Driven Innovation: Research on the application of artificial intelligence (AI), machine learning, and big data analytics to advance research, development, and quality control across foods, pharmaceuticals, medical devices, and cosmetics.
    2. Smart Regulatory Science: Innovative studies leveraging digital technologies, smart manufacturing tracking, and intelligent systems to enhance surveillance, risk prediction, and management science in regulatory frameworks.
  6. Regulatory Science and Public Health Policy
    1. Research that informs regulatory policies and frameworks, and international standards for the safety and quality of foods, pharmaceuticals, medical devices and cosmetics.
    2. Studies on the application of in silico tools, data science, and modeling in regulatory decision-making for foods, pharmaceuticals, medical devices, and cosmetics.

Article Types

JFDA accepts the following contributions:

  1. Original Articles: Full-length reports of novel and significant research.
  2. Review Articles: Critical evaluations of existing literature (typically by invitation or prior consultation).
  3. Case Reports and Research Notes: Concise reports on urgent findings or unique technical incidents.

Benefits to Authors

Authors benefit from a rigorous peer-review process and high global visibility through indexing in SCIE, Medline (PubMed), EMBASE, and DOAJ. As an open-access journal, JFDA provides free access to all published content, ensuring your research achieves maximum reach and impact.